# Modelling the Role of Diagnosis, Treatment, and Health Education on Multidrug-Resistant Tuberculosis Dynamics

Authors: M. Maliyoni; P. M. M. Mwamtobe; S. D. Hove-Musekwa; J. M. Tchuenche
Journal: ISRN Biomathematics
 (2012)

---

## Abstract

Tuberculosis, an airborne disease affecting almost a third of the world’s population remains
one of the major public health burdens globally, and the resurgence of multidrug-resistant tuberculosis in some parts of sub-Saharan Africa calls for concern. To gain insight into its qualitative dynamics at the population level, mathematical modeling which require as inputs key demographic and epidemiological information can fill in gaps where field and lab data are not readily available. A deterministic model for the transmission dynamics of multi-drug resistant tuberculosis to assess the impact of diagnosis, treatment, and health education is formulated. The model assumes that exposed individuals develop active tuberculosis due to endogenous activation and exogenous re-infection. Treatment is offered to all infected individuals except those latently infected with multi-drug resistant tuberculosis. Qualitative analysis using the theory of dynamical systems shows that, in addition to the disease-free equilibrium, there exists a unique dominant locally asymptotically stable equilibrium corresponding to each strain. Numerical simulations suggest that, at the current level of control strategies (with Malawi as a case study), the drug-sensitive tuberculosis can be completely eliminated from the population, thereby reducing multi-drug resistant tuberculosis.


---

## Body

## 1. Introduction

Tuberculosis (TB) is a bacterial infection that is fatal if untreated timely [1]. It is an airborne disease caused by the mycobacterium tuberculosis and primarily affects the lungs (it can also affect the central nervous system, the lymphatic system, the brain, spine, and the kidneys). Approximately one-third of the world’s population is affected [2]. In 1993, concerned with the rising cases of deaths and the new infection rate which were occurring at one per second, the World Health Organization (WHO) declared TB as a global emergency. This resurgence has been closely linked with environmental and social changes that compromised people’s immune system [3]. Out of the 1.7 billion people estimated to be infected with TB, 1.3 billion lived in developing countries [2].Active TB individuals can infect on average 10–15 other people per year if left untreated [12]. TB progression from inactive (latent) infection to active infection varies from one person to another. People suffering from AIDS have a greater risk of developing active TB with about 50% chance of developing active TB within 2 months and a 5 to 10% chance of developing active TB each year thereafter [1]. TB is treatable and curable if it is diagnosed and treated before it becomes severe [13]. WHO stresses that treatment for TB should not be undertaken unless the diagnosis is confirmed [14]. Currently five drugs are available: isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin [13]. A combination of these drugs is required to prevent the development of drug-resistance, requiring 6–9 months of continued treatment to be effective [15].Multidrug-resistant tuberculosis (MDR-TB) is a form of TB that is resistant to at least the two main first-line anti-TB drugs, isoniazid and rifampicin [1]. There were an estimated 0.5 million cases of MDR-TB in 2007 worldwide [14]. Drug-resistant strains are far more difficult but not impossible to treat, despite being too expensive [12]. The most important factor in preventing drug-resistant TB is to ensure full compliance with anti-TB treatment [1]. It is recommended that patients take the pills in the presence of a medical professional, an approach referred to as the directly observed therapy strategy (DOTS).Given the scarcity of complete data, partial data obtained from the Malawi National TB Control Program [4] will be used for numerical simulations. Other parameter values are from the literature or simply assumed for the purpose of illustration. Malawi which endorsed the DOTS program since 1984 is a landlocked country in Central-Southern Africa, sharing common borders with Tanzania, Zambia, and Mozambique. The country has an estimated total population of 12.8 million and has a surface area of 118,480 km2, a quarter of which is occupied by Lake Malawi [4]. In July 2007, there was a commitment to treat all known MDR-TB cases in Malawi. By October 2007, some patients were identified, retested and a recommendation was made to start them on second-line treatment under DOTS. However, the effectiveness of the whole exercise is yet to be established as field and lab data are not yet available. Even when available, the data may not reflect the true picture because some hospitals do not collect monthly sputum specimens for checking conversion to negativity [4]. According to the 2007 tuberculosis case finding statistics, 26,299 cases were reported countrywide [4]. This is 3% less than the cases that were reported in 2006. For 2007/2008, WHO estimates that TB case detection rate for Malawi was 46%. Since TB-infected people progress faster to active TB if they are HIV positive, all TB patients are tested for HIV. Out of the 26,299 TB patients registered for anti-TB treatment, 22,744 (86%) were tested for HIV and 15,491 (68%) were found to be HIV positive [4].Two-strain TB models that considered different interventions have been developed [5, 16, 17]. There are fundamental differences with this study. In addition to treatment, individuals are further classified based on their knowledge about health information (education) on the importance of completing their TB dosage. Also, infectious drug-sensitive individuals are diagnosed for any development of drug-resistance. Since much remains unknown about the transmission of drug-resistant TB strains, another novelty of this study is the consideration of two cases whereby an individual can get infected with MDR-TB. The first case is when latently infected individuals with drug sensitive TB come into adequate contact with an infectious MDR-TB individual and transmission takes place. The second one is when a drug sensitive TB individual can be reinfected with MDR-TB, which might also be due to incomplete treatment. Furthermore, fast and slow progression to active TB as well as endogenous re-activation and exogenous re-infection for both drug sensitive and resistant strains is accounted for.This paper is organized as follows. In Section2, we formulate and analyze the model. The potential impact of the various control strategies is numerically investigated in Section 3. In Section 4, we discuss the relevance of the results and possible future work.


## 2. Model Construction and Analysis

We consider a two-strain TB model with three interventions. The model is defined as a set of nonlinear ordinary differential equations based upon specific biological and intervention assumptions about the transmission dynamics of MDR-TB. The host population is subdivided into various classes according to their disease status: susceptible individuals (S), individuals exposed to drug sensitive TB only (Es), infectious individuals with drug sensitive TB (Is), individuals exposed to MDR-TB (Er), infectious individuals with MDR-TB (Ir), and individuals who have recovered from the disease (R). Susceptible individuals are recruited at a constant rate, Λ. These individuals will be infected with the tubercle bacillus if they come into effective contact with an active TB case at a rate λi, where the subscript i=s,r denotes sensitive and MDR strains, respectively. The force of infection λi is defined as λi=(cβiIi)/N, where βi is the probability that an individual is infected by one infectious individual, and c is the percapita contact rate.Progression from respective exposed classes to infectious classes is due to exogenous re-infection and endogenous reactivation. Thus, due to exogenous re-infection, individuals inEs and Er classes progress to active TB classes, Is and Ir, at the rate γsλs and γrλr, respectively (γr is the re-infection rate of exposed individuals with MDR-TB γs is similarly defined). Latently infected individuals with drug sensitive and MDR-TB strains will progress to active classes Is and Ir at the rates k1 and k2, respectively, due to endogenous reactivation. Individuals in Is and Ir classes are treated at the rate ϕs and ϕr, respectively (realistically, it is possible that ϕs=ϕr). They then progress to recovered class, R, if successfully treated. However, some individuals in Is class will recover naturally at a rate φ and move to R class. Also, exposed individuals in Es and infectious individuals in Is can acquire MDR-TB if they are in contact with infectious MDR-TB individuals at a rate λr and will then enter Ir class.Infectious individuals inIs class receive treatment at a rate ϕr, a proportion p of which responds positively to the treatment, whereas a proportion q partially responds to the treatment and as such they go back to Es class. The remaining proportion (1-(p+q)) will not complete the treatment which may result in the development of MDR-TB and these individuals move to Er class. In addition, health education is offered to infectious individuals with drug sensitive strains only at a rate a. This is due to the nature of the disease, that is, one is diagnosed with drug sensitive TB (at a rate σ in this case) which later progress to MDR-TB if treatment compliance is disregarded [13]. Both ϕr and σ also describe a consequence of incomplete treatment, and as such, treatment rate ϕr is also a result of a diagnosis.Susceptible individuals who become infected progress faster to active drug sensitive TB, that is, fromS to Is class at a rate ρs and to resistant strain class Ir, at a rate ρr; this might be due to other immunocompromised factors such as HIV and malaria that weakens individuals’ immune systems leaving them very vulnerable to TB attack. Thus, (1-ρs) and (1-ρr) denote slow progression to active drug sensitive and MDR strains, respectively. We assume that recovery is non permanent and as such recovered individuals are infected with drug sensitive TB at a rate λs, move to Es class where they become infected with MDR-TB at a rate λr to move into the Er class. Furthermore, infectious individuals in Is class die due to the disease at a rate ds and those in Ir class die at a rate dr. All individuals in different subgroups die naturally at a rate μ. A schematic diagram of the model is depicted in Figure 1, and the associated parameters are described in Table 1.Figure 1
Compartmental diagram and flows for a two-strain tuberculosis transmission model with diagnosis, treatment, and health education.With the pervious assumptions, terminology and inter-relations between the parameters and variables as described by Figure1, the dynamics of the MDR-TB model can be described by the following deterministic system of nonlinear ordinary differential equations:
(1)S′(t)=Λ-(λs+λr)S-μS,Es′(t)=((1-ρs)S+R)λs-(γsλs+λr)Es-(ϕs+k1+μ)Es+qϕrIs,Is′(t)=ρsλsS+(γsλs+k1)Es-λrIs-(ds+apϕr+φs+σ+μ)Is,Er′(t)=((1-ρr)S+R)λr+(1-(p+q))ϕrIs-(λs+γrλr+k2+μ)Er,Ir′(t)=ρrλrS+(λs+γrλr+k2)Er+λrEs+λrIs+σIs-(dr+ϕ+φr+μ)Ir,R′(t)=(apϕr+φs)Is+ϕsEs+(ϕ+φr)Ir-(λs+λr)R-μR,
where the force of infection λs=cβs(Is/N), λr=cβr(Ir/N). The initial conditions are S(0)=S0,Es(0)=Es0,Is(0)=Is0,Er(0)=Er0,Ir(0)=Ir0,R(0)=R0. The total population N (say) of system (1) is given by N=S+Es+Is+Er+Ir+R. Model system (1) monitors a human population; therefore, all its associated parameters and state variables are assumed to be nonnegative for all t>0. Thus, the feasible solutions of system (1) are well-defined in
(2)Γ={(S(t),Es(t),Is(t),Er(t),Ir(t),R(t))∈R+6:N≤Λμ},
which is positively invariant and attracting and it is sufficient to consider solutions in Γ [18]. Furthermore, existence, uniqueness, and continuation of results for system (1) hold in this region. Also, all solutions of model system (1) starting in Γ remain in Γ for all t≥0.


### 2.1. The Disease-Free Equilibrium and Its Stability

In the absence of infection (i.e.,Es*=Er*=Is*=Ir*=0), model system (1) has a disease-free equilibrium E0 given by
(3)E0=(S0,Es0,Is0,Er0,Ir0,R0)=(Λμ,0,0,0,0,0).
The potential intensity of transmission and the dynamics of a disease are often investigated in terms of the reproductive number, which represents the mean number of secondary cases a typical single infected individual will generate in a totally naive/susceptible population during his/her entire period of infectiousness. The linear stability of the disease-free equilibrium E0 is investigated using the next generation matrix for system (1) [19]. To this effect, we compute the effective reproduction number Re, the threshold for endemic persistence and epidemic spread of the disease. This is an important nondimensional quantity in epidemiology as it sets the threshold for predicting a disease outbreak and for evaluating its control strategies [20]. Therefore, whether a disease becomes persistent or dies out in a community depends on the size of this threshold parameter. Mathematically, Re is the spectral radius of the next-generation matrix [19]. The next-generation matrix calculation (see details in Appendix A) shows that the effective reproduction number (or epidemic threshold) is
(4)Re=max⁡{Rs,Rr},
where
(5)Rs=cβs(μρs+ϕsρs+k1)(ϕs+k1+μ)(ds+aϕr+φs+σ+μ)-qϕrk1,Rr=cβr(k2+μρr)(k2+μ)(dr+ϕ+φr+μ).Rs and Rr are, respectively, the reproduction numbers for drug-sensitive TB strain only and MDR-TB strain only. Re measures the average number of new infections generated by a typical infectious individual in a community where intervention strategies are in place. Thus, in the absence of diagnosis, treatment, and health education (i.e., ϕs=ϕr=ϕ=a=σ=0), (A.7) reduces to
(6)R0s=cβs(k1+μρs)(k1+μ)(ds+φs+σ+μ),R0r=cβr(k2+μρr)(k2+μ)(dr+φr+σ+μ),R0=max{R0s,R0r}. The threshold quantity R0 is the basic reproduction number of infection representing the average number of new infections generated by a single infective individual in a completely naive population. Each term in Rs and Rr has an epidemiological interpretation. For the drug-sensitive reproduction number,(i)
k1/(ϕs+k1+μ) is the expected fraction of individuals that will progress from Es class to Is;(ii)
1/(ds+aϕr+φs+σ+μ) is the expected time infectious individuals with drug-sensitive TB spend in Is class.A similar interpretation caters for the drug-resistant reproduction number. Thus, from [19] the following result holds.Theorem 1.
The disease-free equilibriumE0 of model system (1) is locally asymptotically stable if Re<1, that is, Rs<1 and Rr<1, and unstable if Re>1, that is, Rs>1 and Rr>1.


### 2.2. The Endemic Equilibria

For system (1), there are three possible endemic equilibria; two boundary equilibrium points which are E1 (exists only when drug-sensitive strain is present) and E2 (exists only when drug-resistant strain is present) and the equilibrium point E3 which exists when both strains are present or coexist.


#### 2.2.1. The Drug-Sensitive TB-Only Endemic Equilibrium

This is obtained by setting classesEr=Ir=0. This reduces system (1) to
(7)S′(t)=Λ-λsS-μS,Es′(t)=((1-ρs)S+R)λs-γsλsEs-(ϕs+k1+μ)Es+qϕrIs,Is′(t)=ρsλsS+(γsλs+k1)Es-(ds+aϕr+φs+σ+μ)Is,R′(t)=(apϕr+φs)Is+ϕsEs-(λs+μ)R.
The drug-sensitive TB-only equilibrium in terms of the equilibrium value of the force of infection λs* is given by E1=(S*,Es*,Is*,R*,0,0), where
(8)S*=Λλs*+μ,Es*=a1λs*2+a2λs*(λs*+μ)(b1λs*2+b2λs*+b3),Is*=ρsλs*Λ(b1λs*2+b2λs*+b3)+(γsλs*+k1)(a1λs*2+a2λs*)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),R*=λs*(a3λs*2+a4λs*+a5)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),
with
(9)a1=Λ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs-(apϕr+φs)ρs],a2=μΛ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs],a3=b1(apϕr+φs)Λρs+a1apϕrγs,a4=b2(apϕr+φs)Λρs+a1[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)]+a2(apϕr+φs)γs,a5=b3(apϕr+φs)Λρs+a2[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)],b1=γs(ds+aϕr+φs+σ+μ)-γsqϕr-(apϕr+φs)γs,b2=(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)+μγs(ds+aϕr+φs+σ+μ)-qϕr(μγs+k1)-((apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)),b3=μ(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-μqϕrk1.
Substituting E1 into the relationship λs*=(cβsIs*)/N, we obtain the drug-sensitive TB-only endemic equilibrium that satisfies the following polynomial:
(10)λs*h(λs*)=λs*(A1λs*2+B1λs*+C1)=0,
where
(11)A1=a1[μ(ds+aϕr+φs+σ+μ)+k1]+a2[(ds+aϕr+φs+σ+μ)+γs]+b2Λ[(ds+aϕr+φs+σ+μ)+ρs]+b1μΛ(ds+aϕr+φs+σ+μ)+a4-cβs(ρsΛb1+a1γs),B1=a2[k1+μ(ds+aϕr+φs+σ+μ)]+b3Λ(ds+aϕr+φs+σ+μ+ρs)+b2Λμ(ds+aϕr+φs+σ+μ)+a5-cβs(b3ρsΛ+a2k1),C1=((ds+aϕr+φs+σ+μ+ρs)(ϕs+k1+μ)-k1qϕr)×(1-Rs).
The solution λs*=0 in (10) corresponds to the disease-free equilibrium and h(λs*)=0 corresponds to the existence of multiple equilibria. The coefficient A1 is always positive and C1 is positive if Rs is less than unity and negative if Rs is greater than unity. Thus, we have established the following result.Theorem 2.
The drug sensitive TB only model system (7) has(i)
precisely one unique endemic equilibrium ifC1<0⇔Rs>1,(ii)
precisely one unique endemic equilibrium ifB1<0 and C1=0 or B12-4A1C1=0,(iii)
precisely two endemic equilibria ifC1>0, B1<0 and B12-4A1C1>0,(iv)
otherwise, there is no endemic equilibrium.Condition(iii) implies that the dynamical phenomenon of backward bifurcation where a stable endemic equilibrium coexists with a stable disease-free equilibrium when the associated reproduction number is less than unity. This has important implications for disease control. In such a scenario, the classical requirement of the reproduction number being less than unity becomes only a necessary, but not a sufficient condition for disease elimination. To find the backward bifurcation point, we set the discriminant B12-4A1C1 to zero. Making Rs the subject of formula, we obtain
(12)Rsc=1-B124A1((ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-k1qϕr).
Hence, it can be shown that backward bifurcation occurs for values of Rs in the range Rsc<Rs<1 (see Figure 2). Figure 2 shows a backward bifurcation diagram of model system (7). From the diagram, we observe that if Rs<1 and then increases to unity, the number of TB cases increases abruptly thus, the disease-free equilibrium coexist with the endemic equilibrium implying that; the disease can invade the population to a relatively high endemic level. In addition, decreasing Rs to its former level will not necessarily make the disease disappear. This is a consequence of the exogenous re-infection feature of TB. Hence, exogenous re-infection is capable of sustaining TB even when the reproduction number is below one [21]. However, backward bifurcation is illustrated by specific choice of parameters which may not be epidemiologically realistic.Figure 2
Backward bifurcation diagram of the force of infectionλs* for drug sensitive TB only model (7), against the drug sensitive TB reproduction number, Rs which occurs at Rs=1 for an arbitrary set of parameter values. The acronyms EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.


#### 2.2.2. The Drug-Resistant TB Only Endemic Equilibrium

This is obtained by settingEs=Is=0 in model system (1). Hence, system (1) becomes
(13)S′(t)=Λ-λrS-μS,Er′(t)=(1-ρr)λrS+λrR-(γrλr+k2+μ)Er,Ir′(t)=ρrλrS+(γrλr+k2)Er-(dr+ϕ+φr+μ)Ir,R′(t)=(ϕ+φr)Ir-(λr+μ)R,
so that N=S+Er+Ir+R. Therefore, the drug-resistant TB only equilibrium in terms of the equilibrium value of the force of infection λr* is given by E2=(S**,0,0,Er**,Ir**,R**)=(S**,Er**,Ir**,R**), where
(14)S**=Λλr*+μ,Er**=(1-ρr)Λλr*(m4λr*2+m5λr*+m6)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6)+ϕλr*(m1λr*2+m2λr*+m3)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6),Ir**=m1λr*2+m2λr*+m3m4λr*2+m5λr*+m6,R**=ϕ(m1λr*2+m2λr*+m3)(λr*+μ)(m4λr*2+m5λr*+m6),
with
(15)m1=Λγr,m2=μΛρr,m3=Λk2,m4=γr(dr+μ),m5=(dr+ϕ+φr+μ)(k2+μ+μγr)-(ϕ+φr)k2,m6=μ(k2+μ)(dr+ϕ+φr+μ).
Substituting E2 into the equation λr*=(cβrIr**)/N, we obtain an endemic equilibrium of the drug-resistant TB only that satisfies the polynomial given by
(16)λr*g(λr*)=λr*(Aλr*2+Bλr*+C)=0,
where
(17)A=m4Λ(k2+μ)+m5Λ(γr+(1-ρr))+m1(k2+μ)(ϕ+φr+μ)+m2((ϕ+φr)+γrμ+k2+μ+(ϕ+φr)γr)+m3γr-cβr((μγr+k2+μ)m1+m2γr),B=m5Λ(k2+μ)+m6Λ(γr+(1-ρr))+m2(k2+μ)(ϕ+φr+μ)+m3(ϕ+μγr+k2+μ+(ϕ+φr)γr)-cβr(m1(k2+μ)μ+m2(μγr+k2+μ)+m3γr),C=μ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ)(1-Rr).
The root λr*=0 in (16) corresponds to E0 (its stability has already been established) and g(λr*)=0 can be analyzed for the possibility of existence of multiple equilibria. It is worth mentioning here that the coefficient A is always positive and C is positive if Rr<1 and negative if Rr>1, hence, the following result.Theorem 3.
The drug-resistant TB only model (13) has(1)
precisely one unique endemic equilibrium ifC<0⟺Rr>1,(2)
precisely one unique endemic equilibrium ifB<0 and C=0 or B2-4AC=0,(3)
precisely two endemic equilibria ifC>0, B<0 and B2-4AC>0,(4)
otherwise there is no endemic equilibrium.The backward bifurcation point can be found by setting the discriminantB2-4AC to zero. Then, making Rr the subject of the formula, we obtain
(18)Rrc=1-B24Aμ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ),
from which it can be shown that backward bifurcation occurs for values of Rr in the range Rrc<Rr<1. The following result provides a condition for the existence of the drug-resistant TB only endemic equilibrium point, E2.Theorem 4.
The drug-resistant TB only endemic equilibriumE2 exists whenever Rr>1.Proof.
Solving forλr* in (16), we obtain
(19)λr*=-B+B2-4AC2A.
The disease is endemic when λr*>0 which occurs if and only if
(20)B2-4AC>B2⟹4Aμ(k2+μ)(dr+ϕ+φr+μ)×(μγr+k2+μ)(1-Rr)<0⟹Rr>1.
Thus,E2 exists whenever Rr>1.Again, using the Center Manifold theory [22], the local asymptotic stability of E2 is established (see details in Appendix B). The bifurcation diagram of the drug-resistant TB only model is illustrated in Figure 3.Figure 3
Backward bifurcation diagram of the drug-resistant TB only model (13), for an arbitrary set of parameter values. EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.Figure3 illustrates a case of a backward bifurcation of system (13). As Rr approaches unity, it can be seen from the diagram that the number of secondary transmission suddenly increases giving rise to a situation whereby the disease-free equilibrium coexist with the endemic equilibrium.


#### 2.2.3. Two-Strain Model: Drug Sensitive and MDR-TB Endemic Equilibrium

Having analyzed the dynamics of the two submodels, the full drug sensitive and MDR-TB model is now considered. Its endemic equilibrium occurs when both drug sensitive and MDR-TB strains circulate in the community and is denoted by(21)E3=(S***,Es***,Is***,Er***,Ir***,R***).
It is a daunting task to explicitly express E3 in terms of the equilibrium value of the force of infection λrs*. As in the previous sections, it can be shown, using the next-generation method that the associated reproduction number for the full model is Re=max{Rs,Rr}, where Rs and Rr are, respectively, the reproduction numbers of drug sensitive and drug-resistant TB only sub-models given earlier. Re=max{Rs,Rr} implies that the two TB strains (drug sensitive and drug-resistant) escalate each other and competitive exclusion may occur.IfRe=max{Rs,Rr}, then from Theorem 2, the drug sensitive TB only sub-model has a backward bifurcation for values of Rs such that Rsc<Rs<1 and Theorem 3 showed that the drug-resistant TB only sub-model exhibits backward bifurcation for values of Rr such that Rrc<Rr<1. Thus, the two-strain model will also exhibit the phenomenon of backward bifurcation whenever Re<1, and consequently, the coexistence endemic equilibrium E3 is only locally asymptotically stable when Re>1.The existence of multiple endemic equilibria is of general interest far beyond tuberculosis epidemiology. An important principle in theoretical biology is that of competitive exclusion which states that no two species can forever occupy the same ecological niche [23]. The system studied has the requisite in which the principle of competitive exclusion holds. Since model (1) exhibits the phenomenon of backward bifurcation thereby implying that the two-strain model is only locally stable, the strain with the large reproduction number colonizes the other strain [24].


## 2.1. The Disease-Free Equilibrium and Its Stability

In the absence of infection (i.e.,Es*=Er*=Is*=Ir*=0), model system (1) has a disease-free equilibrium E0 given by
(3)E0=(S0,Es0,Is0,Er0,Ir0,R0)=(Λμ,0,0,0,0,0).
The potential intensity of transmission and the dynamics of a disease are often investigated in terms of the reproductive number, which represents the mean number of secondary cases a typical single infected individual will generate in a totally naive/susceptible population during his/her entire period of infectiousness. The linear stability of the disease-free equilibrium E0 is investigated using the next generation matrix for system (1) [19]. To this effect, we compute the effective reproduction number Re, the threshold for endemic persistence and epidemic spread of the disease. This is an important nondimensional quantity in epidemiology as it sets the threshold for predicting a disease outbreak and for evaluating its control strategies [20]. Therefore, whether a disease becomes persistent or dies out in a community depends on the size of this threshold parameter. Mathematically, Re is the spectral radius of the next-generation matrix [19]. The next-generation matrix calculation (see details in Appendix A) shows that the effective reproduction number (or epidemic threshold) is
(4)Re=max⁡{Rs,Rr},
where
(5)Rs=cβs(μρs+ϕsρs+k1)(ϕs+k1+μ)(ds+aϕr+φs+σ+μ)-qϕrk1,Rr=cβr(k2+μρr)(k2+μ)(dr+ϕ+φr+μ).Rs and Rr are, respectively, the reproduction numbers for drug-sensitive TB strain only and MDR-TB strain only. Re measures the average number of new infections generated by a typical infectious individual in a community where intervention strategies are in place. Thus, in the absence of diagnosis, treatment, and health education (i.e., ϕs=ϕr=ϕ=a=σ=0), (A.7) reduces to
(6)R0s=cβs(k1+μρs)(k1+μ)(ds+φs+σ+μ),R0r=cβr(k2+μρr)(k2+μ)(dr+φr+σ+μ),R0=max{R0s,R0r}. The threshold quantity R0 is the basic reproduction number of infection representing the average number of new infections generated by a single infective individual in a completely naive population. Each term in Rs and Rr has an epidemiological interpretation. For the drug-sensitive reproduction number,(i)
k1/(ϕs+k1+μ) is the expected fraction of individuals that will progress from Es class to Is;(ii)
1/(ds+aϕr+φs+σ+μ) is the expected time infectious individuals with drug-sensitive TB spend in Is class.A similar interpretation caters for the drug-resistant reproduction number. Thus, from [19] the following result holds.Theorem 1.
The disease-free equilibriumE0 of model system (1) is locally asymptotically stable if Re<1, that is, Rs<1 and Rr<1, and unstable if Re>1, that is, Rs>1 and Rr>1.


## 2.2. The Endemic Equilibria

For system (1), there are three possible endemic equilibria; two boundary equilibrium points which are E1 (exists only when drug-sensitive strain is present) and E2 (exists only when drug-resistant strain is present) and the equilibrium point E3 which exists when both strains are present or coexist.


### 2.2.1. The Drug-Sensitive TB-Only Endemic Equilibrium

This is obtained by setting classesEr=Ir=0. This reduces system (1) to
(7)S′(t)=Λ-λsS-μS,Es′(t)=((1-ρs)S+R)λs-γsλsEs-(ϕs+k1+μ)Es+qϕrIs,Is′(t)=ρsλsS+(γsλs+k1)Es-(ds+aϕr+φs+σ+μ)Is,R′(t)=(apϕr+φs)Is+ϕsEs-(λs+μ)R.
The drug-sensitive TB-only equilibrium in terms of the equilibrium value of the force of infection λs* is given by E1=(S*,Es*,Is*,R*,0,0), where
(8)S*=Λλs*+μ,Es*=a1λs*2+a2λs*(λs*+μ)(b1λs*2+b2λs*+b3),Is*=ρsλs*Λ(b1λs*2+b2λs*+b3)+(γsλs*+k1)(a1λs*2+a2λs*)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),R*=λs*(a3λs*2+a4λs*+a5)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),
with
(9)a1=Λ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs-(apϕr+φs)ρs],a2=μΛ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs],a3=b1(apϕr+φs)Λρs+a1apϕrγs,a4=b2(apϕr+φs)Λρs+a1[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)]+a2(apϕr+φs)γs,a5=b3(apϕr+φs)Λρs+a2[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)],b1=γs(ds+aϕr+φs+σ+μ)-γsqϕr-(apϕr+φs)γs,b2=(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)+μγs(ds+aϕr+φs+σ+μ)-qϕr(μγs+k1)-((apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)),b3=μ(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-μqϕrk1.
Substituting E1 into the relationship λs*=(cβsIs*)/N, we obtain the drug-sensitive TB-only endemic equilibrium that satisfies the following polynomial:
(10)λs*h(λs*)=λs*(A1λs*2+B1λs*+C1)=0,
where
(11)A1=a1[μ(ds+aϕr+φs+σ+μ)+k1]+a2[(ds+aϕr+φs+σ+μ)+γs]+b2Λ[(ds+aϕr+φs+σ+μ)+ρs]+b1μΛ(ds+aϕr+φs+σ+μ)+a4-cβs(ρsΛb1+a1γs),B1=a2[k1+μ(ds+aϕr+φs+σ+μ)]+b3Λ(ds+aϕr+φs+σ+μ+ρs)+b2Λμ(ds+aϕr+φs+σ+μ)+a5-cβs(b3ρsΛ+a2k1),C1=((ds+aϕr+φs+σ+μ+ρs)(ϕs+k1+μ)-k1qϕr)×(1-Rs).
The solution λs*=0 in (10) corresponds to the disease-free equilibrium and h(λs*)=0 corresponds to the existence of multiple equilibria. The coefficient A1 is always positive and C1 is positive if Rs is less than unity and negative if Rs is greater than unity. Thus, we have established the following result.Theorem 2.
The drug sensitive TB only model system (7) has(i)
precisely one unique endemic equilibrium ifC1<0⇔Rs>1,(ii)
precisely one unique endemic equilibrium ifB1<0 and C1=0 or B12-4A1C1=0,(iii)
precisely two endemic equilibria ifC1>0, B1<0 and B12-4A1C1>0,(iv)
otherwise, there is no endemic equilibrium.Condition(iii) implies that the dynamical phenomenon of backward bifurcation where a stable endemic equilibrium coexists with a stable disease-free equilibrium when the associated reproduction number is less than unity. This has important implications for disease control. In such a scenario, the classical requirement of the reproduction number being less than unity becomes only a necessary, but not a sufficient condition for disease elimination. To find the backward bifurcation point, we set the discriminant B12-4A1C1 to zero. Making Rs the subject of formula, we obtain
(12)Rsc=1-B124A1((ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-k1qϕr).
Hence, it can be shown that backward bifurcation occurs for values of Rs in the range Rsc<Rs<1 (see Figure 2). Figure 2 shows a backward bifurcation diagram of model system (7). From the diagram, we observe that if Rs<1 and then increases to unity, the number of TB cases increases abruptly thus, the disease-free equilibrium coexist with the endemic equilibrium implying that; the disease can invade the population to a relatively high endemic level. In addition, decreasing Rs to its former level will not necessarily make the disease disappear. This is a consequence of the exogenous re-infection feature of TB. Hence, exogenous re-infection is capable of sustaining TB even when the reproduction number is below one [21]. However, backward bifurcation is illustrated by specific choice of parameters which may not be epidemiologically realistic.Figure 2
Backward bifurcation diagram of the force of infectionλs* for drug sensitive TB only model (7), against the drug sensitive TB reproduction number, Rs which occurs at Rs=1 for an arbitrary set of parameter values. The acronyms EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.


### 2.2.2. The Drug-Resistant TB Only Endemic Equilibrium

This is obtained by settingEs=Is=0 in model system (1). Hence, system (1) becomes
(13)S′(t)=Λ-λrS-μS,Er′(t)=(1-ρr)λrS+λrR-(γrλr+k2+μ)Er,Ir′(t)=ρrλrS+(γrλr+k2)Er-(dr+ϕ+φr+μ)Ir,R′(t)=(ϕ+φr)Ir-(λr+μ)R,
so that N=S+Er+Ir+R. Therefore, the drug-resistant TB only equilibrium in terms of the equilibrium value of the force of infection λr* is given by E2=(S**,0,0,Er**,Ir**,R**)=(S**,Er**,Ir**,R**), where
(14)S**=Λλr*+μ,Er**=(1-ρr)Λλr*(m4λr*2+m5λr*+m6)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6)+ϕλr*(m1λr*2+m2λr*+m3)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6),Ir**=m1λr*2+m2λr*+m3m4λr*2+m5λr*+m6,R**=ϕ(m1λr*2+m2λr*+m3)(λr*+μ)(m4λr*2+m5λr*+m6),
with
(15)m1=Λγr,m2=μΛρr,m3=Λk2,m4=γr(dr+μ),m5=(dr+ϕ+φr+μ)(k2+μ+μγr)-(ϕ+φr)k2,m6=μ(k2+μ)(dr+ϕ+φr+μ).
Substituting E2 into the equation λr*=(cβrIr**)/N, we obtain an endemic equilibrium of the drug-resistant TB only that satisfies the polynomial given by
(16)λr*g(λr*)=λr*(Aλr*2+Bλr*+C)=0,
where
(17)A=m4Λ(k2+μ)+m5Λ(γr+(1-ρr))+m1(k2+μ)(ϕ+φr+μ)+m2((ϕ+φr)+γrμ+k2+μ+(ϕ+φr)γr)+m3γr-cβr((μγr+k2+μ)m1+m2γr),B=m5Λ(k2+μ)+m6Λ(γr+(1-ρr))+m2(k2+μ)(ϕ+φr+μ)+m3(ϕ+μγr+k2+μ+(ϕ+φr)γr)-cβr(m1(k2+μ)μ+m2(μγr+k2+μ)+m3γr),C=μ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ)(1-Rr).
The root λr*=0 in (16) corresponds to E0 (its stability has already been established) and g(λr*)=0 can be analyzed for the possibility of existence of multiple equilibria. It is worth mentioning here that the coefficient A is always positive and C is positive if Rr<1 and negative if Rr>1, hence, the following result.Theorem 3.
The drug-resistant TB only model (13) has(1)
precisely one unique endemic equilibrium ifC<0⟺Rr>1,(2)
precisely one unique endemic equilibrium ifB<0 and C=0 or B2-4AC=0,(3)
precisely two endemic equilibria ifC>0, B<0 and B2-4AC>0,(4)
otherwise there is no endemic equilibrium.The backward bifurcation point can be found by setting the discriminantB2-4AC to zero. Then, making Rr the subject of the formula, we obtain
(18)Rrc=1-B24Aμ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ),
from which it can be shown that backward bifurcation occurs for values of Rr in the range Rrc<Rr<1. The following result provides a condition for the existence of the drug-resistant TB only endemic equilibrium point, E2.Theorem 4.
The drug-resistant TB only endemic equilibriumE2 exists whenever Rr>1.Proof.
Solving forλr* in (16), we obtain
(19)λr*=-B+B2-4AC2A.
The disease is endemic when λr*>0 which occurs if and only if
(20)B2-4AC>B2⟹4Aμ(k2+μ)(dr+ϕ+φr+μ)×(μγr+k2+μ)(1-Rr)<0⟹Rr>1.
Thus,E2 exists whenever Rr>1.Again, using the Center Manifold theory [22], the local asymptotic stability of E2 is established (see details in Appendix B). The bifurcation diagram of the drug-resistant TB only model is illustrated in Figure 3.Figure 3
Backward bifurcation diagram of the drug-resistant TB only model (13), for an arbitrary set of parameter values. EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.Figure3 illustrates a case of a backward bifurcation of system (13). As Rr approaches unity, it can be seen from the diagram that the number of secondary transmission suddenly increases giving rise to a situation whereby the disease-free equilibrium coexist with the endemic equilibrium.


### 2.2.3. Two-Strain Model: Drug Sensitive and MDR-TB Endemic Equilibrium

Having analyzed the dynamics of the two submodels, the full drug sensitive and MDR-TB model is now considered. Its endemic equilibrium occurs when both drug sensitive and MDR-TB strains circulate in the community and is denoted by(21)E3=(S***,Es***,Is***,Er***,Ir***,R***).
It is a daunting task to explicitly express E3 in terms of the equilibrium value of the force of infection λrs*. As in the previous sections, it can be shown, using the next-generation method that the associated reproduction number for the full model is Re=max{Rs,Rr}, where Rs and Rr are, respectively, the reproduction numbers of drug sensitive and drug-resistant TB only sub-models given earlier. Re=max{Rs,Rr} implies that the two TB strains (drug sensitive and drug-resistant) escalate each other and competitive exclusion may occur.IfRe=max{Rs,Rr}, then from Theorem 2, the drug sensitive TB only sub-model has a backward bifurcation for values of Rs such that Rsc<Rs<1 and Theorem 3 showed that the drug-resistant TB only sub-model exhibits backward bifurcation for values of Rr such that Rrc<Rr<1. Thus, the two-strain model will also exhibit the phenomenon of backward bifurcation whenever Re<1, and consequently, the coexistence endemic equilibrium E3 is only locally asymptotically stable when Re>1.The existence of multiple endemic equilibria is of general interest far beyond tuberculosis epidemiology. An important principle in theoretical biology is that of competitive exclusion which states that no two species can forever occupy the same ecological niche [23]. The system studied has the requisite in which the principle of competitive exclusion holds. Since model (1) exhibits the phenomenon of backward bifurcation thereby implying that the two-strain model is only locally stable, the strain with the large reproduction number colonizes the other strain [24].


## 2.2.1. The Drug-Sensitive TB-Only Endemic Equilibrium

This is obtained by setting classesEr=Ir=0. This reduces system (1) to
(7)S′(t)=Λ-λsS-μS,Es′(t)=((1-ρs)S+R)λs-γsλsEs-(ϕs+k1+μ)Es+qϕrIs,Is′(t)=ρsλsS+(γsλs+k1)Es-(ds+aϕr+φs+σ+μ)Is,R′(t)=(apϕr+φs)Is+ϕsEs-(λs+μ)R.
The drug-sensitive TB-only equilibrium in terms of the equilibrium value of the force of infection λs* is given by E1=(S*,Es*,Is*,R*,0,0), where
(8)S*=Λλs*+μ,Es*=a1λs*2+a2λs*(λs*+μ)(b1λs*2+b2λs*+b3),Is*=ρsλs*Λ(b1λs*2+b2λs*+b3)+(γsλs*+k1)(a1λs*2+a2λs*)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),R*=λs*(a3λs*2+a4λs*+a5)(ds+aϕr+φs+σ+μ)(λs*+μ)(b1λs*2+b2λs*+b3),
with
(9)a1=Λ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs-(apϕr+φs)ρs],a2=μΛ[(1-ρs)(ds+aϕr+φs+σ+μ)+qϕrρs],a3=b1(apϕr+φs)Λρs+a1apϕrγs,a4=b2(apϕr+φs)Λρs+a1[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)]+a2(apϕr+φs)γs,a5=b3(apϕr+φs)Λρs+a2[(apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)],b1=γs(ds+aϕr+φs+σ+μ)-γsqϕr-(apϕr+φs)γs,b2=(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)+μγs(ds+aϕr+φs+σ+μ)-qϕr(μγs+k1)-((apϕr+φs)k1+ϕs(ds+aϕr+φs+σ+μ)),b3=μ(ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-μqϕrk1.
Substituting E1 into the relationship λs*=(cβsIs*)/N, we obtain the drug-sensitive TB-only endemic equilibrium that satisfies the following polynomial:
(10)λs*h(λs*)=λs*(A1λs*2+B1λs*+C1)=0,
where
(11)A1=a1[μ(ds+aϕr+φs+σ+μ)+k1]+a2[(ds+aϕr+φs+σ+μ)+γs]+b2Λ[(ds+aϕr+φs+σ+μ)+ρs]+b1μΛ(ds+aϕr+φs+σ+μ)+a4-cβs(ρsΛb1+a1γs),B1=a2[k1+μ(ds+aϕr+φs+σ+μ)]+b3Λ(ds+aϕr+φs+σ+μ+ρs)+b2Λμ(ds+aϕr+φs+σ+μ)+a5-cβs(b3ρsΛ+a2k1),C1=((ds+aϕr+φs+σ+μ+ρs)(ϕs+k1+μ)-k1qϕr)×(1-Rs).
The solution λs*=0 in (10) corresponds to the disease-free equilibrium and h(λs*)=0 corresponds to the existence of multiple equilibria. The coefficient A1 is always positive and C1 is positive if Rs is less than unity and negative if Rs is greater than unity. Thus, we have established the following result.Theorem 2.
The drug sensitive TB only model system (7) has(i)
precisely one unique endemic equilibrium ifC1<0⇔Rs>1,(ii)
precisely one unique endemic equilibrium ifB1<0 and C1=0 or B12-4A1C1=0,(iii)
precisely two endemic equilibria ifC1>0, B1<0 and B12-4A1C1>0,(iv)
otherwise, there is no endemic equilibrium.Condition(iii) implies that the dynamical phenomenon of backward bifurcation where a stable endemic equilibrium coexists with a stable disease-free equilibrium when the associated reproduction number is less than unity. This has important implications for disease control. In such a scenario, the classical requirement of the reproduction number being less than unity becomes only a necessary, but not a sufficient condition for disease elimination. To find the backward bifurcation point, we set the discriminant B12-4A1C1 to zero. Making Rs the subject of formula, we obtain
(12)Rsc=1-B124A1((ds+aϕr+φs+σ+μ)(ϕs+k1+μ)-k1qϕr).
Hence, it can be shown that backward bifurcation occurs for values of Rs in the range Rsc<Rs<1 (see Figure 2). Figure 2 shows a backward bifurcation diagram of model system (7). From the diagram, we observe that if Rs<1 and then increases to unity, the number of TB cases increases abruptly thus, the disease-free equilibrium coexist with the endemic equilibrium implying that; the disease can invade the population to a relatively high endemic level. In addition, decreasing Rs to its former level will not necessarily make the disease disappear. This is a consequence of the exogenous re-infection feature of TB. Hence, exogenous re-infection is capable of sustaining TB even when the reproduction number is below one [21]. However, backward bifurcation is illustrated by specific choice of parameters which may not be epidemiologically realistic.Figure 2
Backward bifurcation diagram of the force of infectionλs* for drug sensitive TB only model (7), against the drug sensitive TB reproduction number, Rs which occurs at Rs=1 for an arbitrary set of parameter values. The acronyms EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.


## 2.2.2. The Drug-Resistant TB Only Endemic Equilibrium

This is obtained by settingEs=Is=0 in model system (1). Hence, system (1) becomes
(13)S′(t)=Λ-λrS-μS,Er′(t)=(1-ρr)λrS+λrR-(γrλr+k2+μ)Er,Ir′(t)=ρrλrS+(γrλr+k2)Er-(dr+ϕ+φr+μ)Ir,R′(t)=(ϕ+φr)Ir-(λr+μ)R,
so that N=S+Er+Ir+R. Therefore, the drug-resistant TB only equilibrium in terms of the equilibrium value of the force of infection λr* is given by E2=(S**,0,0,Er**,Ir**,R**)=(S**,Er**,Ir**,R**), where
(14)S**=Λλr*+μ,Er**=(1-ρr)Λλr*(m4λr*2+m5λr*+m6)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6)+ϕλr*(m1λr*2+m2λr*+m3)(γrλr*+k2+μ)(λr*+μ)(m4λr*2+m5λr*+m6),Ir**=m1λr*2+m2λr*+m3m4λr*2+m5λr*+m6,R**=ϕ(m1λr*2+m2λr*+m3)(λr*+μ)(m4λr*2+m5λr*+m6),
with
(15)m1=Λγr,m2=μΛρr,m3=Λk2,m4=γr(dr+μ),m5=(dr+ϕ+φr+μ)(k2+μ+μγr)-(ϕ+φr)k2,m6=μ(k2+μ)(dr+ϕ+φr+μ).
Substituting E2 into the equation λr*=(cβrIr**)/N, we obtain an endemic equilibrium of the drug-resistant TB only that satisfies the polynomial given by
(16)λr*g(λr*)=λr*(Aλr*2+Bλr*+C)=0,
where
(17)A=m4Λ(k2+μ)+m5Λ(γr+(1-ρr))+m1(k2+μ)(ϕ+φr+μ)+m2((ϕ+φr)+γrμ+k2+μ+(ϕ+φr)γr)+m3γr-cβr((μγr+k2+μ)m1+m2γr),B=m5Λ(k2+μ)+m6Λ(γr+(1-ρr))+m2(k2+μ)(ϕ+φr+μ)+m3(ϕ+μγr+k2+μ+(ϕ+φr)γr)-cβr(m1(k2+μ)μ+m2(μγr+k2+μ)+m3γr),C=μ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ)(1-Rr).
The root λr*=0 in (16) corresponds to E0 (its stability has already been established) and g(λr*)=0 can be analyzed for the possibility of existence of multiple equilibria. It is worth mentioning here that the coefficient A is always positive and C is positive if Rr<1 and negative if Rr>1, hence, the following result.Theorem 3.
The drug-resistant TB only model (13) has(1)
precisely one unique endemic equilibrium ifC<0⟺Rr>1,(2)
precisely one unique endemic equilibrium ifB<0 and C=0 or B2-4AC=0,(3)
precisely two endemic equilibria ifC>0, B<0 and B2-4AC>0,(4)
otherwise there is no endemic equilibrium.The backward bifurcation point can be found by setting the discriminantB2-4AC to zero. Then, making Rr the subject of the formula, we obtain
(18)Rrc=1-B24Aμ(k2+μ)(dr+ϕ+φr+μ)(μγr+k2+μ),
from which it can be shown that backward bifurcation occurs for values of Rr in the range Rrc<Rr<1. The following result provides a condition for the existence of the drug-resistant TB only endemic equilibrium point, E2.Theorem 4.
The drug-resistant TB only endemic equilibriumE2 exists whenever Rr>1.Proof.
Solving forλr* in (16), we obtain
(19)λr*=-B+B2-4AC2A.
The disease is endemic when λr*>0 which occurs if and only if
(20)B2-4AC>B2⟹4Aμ(k2+μ)(dr+ϕ+φr+μ)×(μγr+k2+μ)(1-Rr)<0⟹Rr>1.
Thus,E2 exists whenever Rr>1.Again, using the Center Manifold theory [22], the local asymptotic stability of E2 is established (see details in Appendix B). The bifurcation diagram of the drug-resistant TB only model is illustrated in Figure 3.Figure 3
Backward bifurcation diagram of the drug-resistant TB only model (13), for an arbitrary set of parameter values. EE and DFE represent endemic equilibrium and disease-free equilibrium, respectively.Figure3 illustrates a case of a backward bifurcation of system (13). As Rr approaches unity, it can be seen from the diagram that the number of secondary transmission suddenly increases giving rise to a situation whereby the disease-free equilibrium coexist with the endemic equilibrium.


## 2.2.3. Two-Strain Model: Drug Sensitive and MDR-TB Endemic Equilibrium

Having analyzed the dynamics of the two submodels, the full drug sensitive and MDR-TB model is now considered. Its endemic equilibrium occurs when both drug sensitive and MDR-TB strains circulate in the community and is denoted by(21)E3=(S***,Es***,Is***,Er***,Ir***,R***).
It is a daunting task to explicitly express E3 in terms of the equilibrium value of the force of infection λrs*. As in the previous sections, it can be shown, using the next-generation method that the associated reproduction number for the full model is Re=max{Rs,Rr}, where Rs and Rr are, respectively, the reproduction numbers of drug sensitive and drug-resistant TB only sub-models given earlier. Re=max{Rs,Rr} implies that the two TB strains (drug sensitive and drug-resistant) escalate each other and competitive exclusion may occur.IfRe=max{Rs,Rr}, then from Theorem 2, the drug sensitive TB only sub-model has a backward bifurcation for values of Rs such that Rsc<Rs<1 and Theorem 3 showed that the drug-resistant TB only sub-model exhibits backward bifurcation for values of Rr such that Rrc<Rr<1. Thus, the two-strain model will also exhibit the phenomenon of backward bifurcation whenever Re<1, and consequently, the coexistence endemic equilibrium E3 is only locally asymptotically stable when Re>1.The existence of multiple endemic equilibria is of general interest far beyond tuberculosis epidemiology. An important principle in theoretical biology is that of competitive exclusion which states that no two species can forever occupy the same ecological niche [23]. The system studied has the requisite in which the principle of competitive exclusion holds. Since model (1) exhibits the phenomenon of backward bifurcation thereby implying that the two-strain model is only locally stable, the strain with the large reproduction number colonizes the other strain [24].


## 3. Model Simulations

Graphical representations to support the analytical results are provided using a set of parameter values given in Table1. These values were obtained from the National Tuberculosis Control Programme secretariat (Lilongwe, Malawi). Incomplete data from the National TB Control Program proves to be a major challenge, and the actual values of most of the parameters are not readily available [25]. Therefore, we use values from the literature for the purpose of illustration. We simulate both the drug sensitive and MDR-TB dynamics in the absence of any intervention and when the interventions are present as well as the effect of varying each intervention parameter on the number of infected populations. All figures are generated using the parameter values presented in Table 1 and the following initial conditions S0=14000,Es0=10500,Is0=7500,Er0=6500,Ir0=5500,R=4000. The rationale behind this particular choice of the initial conditions is to capture the dynamics of the epidemic in a small community. TB is a disease with slow dynamics and consequently, TB epidemics must be studied and assessed over extremely long windows in time [26]. The time unit throughout is per year.Table 1
Model Parameter Values.
Description
Symbol
Value
Source
Recruitment rate
Λ
μ
*
1
0
5
Assumed
Natural mortality rate
μ
0.02
[4]
Contact rate
c
2
[5]
DS TB induced death rate
d
s
0.3
[4]
MDR-TB induced death rate
d
r
0.5
[4]
Probability of being infected with drug sensitive TB
β
s
0.4
[6]
Probability of being infected with MDR-TB
β
r
0.5
[5]
Progression rate to active sensitive TB
k
1
0.03
[7]
Progression rate to active MDR-TB
k
2
0.05
[7]
Fast progression rate to active drug sensitive TB
ρ
s
0.2
Assumed
Fast progression rate to active MDR-TB
ρ
r
0.1
[8]
Re-infection rate of exposed individuals with sensitive TB
γ
s
0.4
[9]
Re-infection rate of exposed individuals with MDR-TB
γ
r
0.02
[9]
Natural immunity rate of infectious individuals with sensitive TB
φ
s
0.15
[10]
Natural immunity rate of infectious individuals with MDR-TB
φ
r
0.2
[10]
Treatment rate of latently infected individuals with sensitive TB
ϕ
s
0.2
[4]
Treatment rate of infectious individuals with sensitive TB
ϕ
r
0.3
[4]
Treatment rate of infectious individuals with MDR-TB
ϕ
0.09
[4]
Education rate of infectious individuals with sensitive TB
a
0.6
[4]
Rate of diagnosis
σ
0.3
[11]
Rate of recovery from active TB
p
0.8
[5]
Regression rate to latency after treatment
q
0.2
Assumed(a) Absence of any Intervention Strategy
In the absence of interventions, the susceptible population initially decreases and then increases to its carrying capacity as shown by Figure4(a). On the other hand, the populations of latent drug sensitive TB, infectious drug sensitive TB, latent drug-resistant TB, and infectious drug-resistant TB decrease to an endemic level with increasing time as shown by Figures 4(b), 4(c), 4(d), and 4(e), respectively. This indicates that as long as there are no interventions to control the spread of the disease, the disease will not clear from the population since the basic reproduction number R0=1.4286>1. This result supports the theorem on local stability of endemic equilibrium.Time series of the dynamics of (a) susceptibles (b) latent individuals with sensitive TB, (c) infectious individuals with sensitive TB, (d) latent individuals with resistant TB, (e) infectious individuals with resistant TB and (f) recovered population (without interventions) whenR0=1.4286.
(a)
(b)
(c)
(d)
(e)
(f)(b) With Control Strategies (Presence of Interventions)
When interventions are introduced, improved trends of the populations are observed. For instance, in Figure5(a), the susceptible population increases compared to the case when no interventions are available. Further improved trends can also be seen in Figures 5(b)–5(f). Figures 5(b) and 5(c) indicate that individuals infected with drug sensitive TB decrease and eventually diminish to zero as a result of the interventions. This means that, if the disease threshold is below unity (Re=0.2987), both drug sensitive and resistant strains can be eliminated. Figure 5(e) depicts the time series plot of the population density of infectious individuals with drug-resistant TB which decreases but does not tend to zero. This simply means that the interventions in place are not enough to completely eradicate the epidemic from the population. The observed decrease of the number of drug-resistant TB individuals may be the result of abrupt reductions in the rates of disease progression [27].Time series plots when interventions are introduced:Re=0.2987 and R0=1.4286 of (a) susceptible population, (b) latent individuals with sensitive TB, (c) infectious individuals with sensitive TB, (d) latent individuals with resistant TB, (e) infectious individuals with resistant TB, and (f) recovered population. The blue curve represents the dynamics of the populations without interventions and the red one with interventions.
(a)
(b)
(c)
(d)
(e)
(f)MDR-TB which is difficult to treat, spreads fastest in areas with poor adherence to second-line drug. This poor adherence is frequently caused by shortages of second-line drugs which are quite expensive and as such minimal treatment is offered to those infected. Figure5(f) shows that the recovered population increases as a result of the interventions unlike in Figure 4(f). In other words, we observe that the introduction of treatment, diagnosis, and health education in a TB stricken community reduces the impact of MDR-TB but cannot completely clear it from the community, because higher levels of treatment may lead to an increase of the epidemic size, and the extend to which this occurs depends on the factors such as drug efficacy and resistance development [28]. Figure 6(a) shows that diagnosis of infectious individuals with drug sensitive TB to determine whether or not the infection has developed resistance to drugs is very crucial in MDR-TB control. More infectious individuals with sensitive TB needs effective treatment that should correlate with the diagnosis levels. In addition, diagnosis is very important to detect  the number of people who have developed resistant strains and are eligible to the second-line treatment to prevent the infection from a possible spread. As for the sick individuals with MDR-TB, treatment of the infection is paramount as indicated by Figure 6(b). Also, from Figure 6(b), education campaigns alone cannot curb or reduce the infection but work hand in hand with treatment as well as diagnosis. In other words, Figure 6 suggests that all individuals diagnosed with MDR-TB should be educated on the importance of treatment compliance and completion.Impact of the different interventions under study on the dynamics of (a) infectious population with drug-sensitive TB and (b) infectious population with drug-resistant TB.
(a)
(b)


### 3.1. Dynamics of the Populations under Different Interventions

#### 3.1.1. The Effect of Treatment on MDR-TB Dynamics

It is assumed under this scenario that treatment is given to latent and infectious individuals with drug sensitive TB as well as infectious individuals with MDR-TB. We then investigate the impact of each of these control measures on all the infected populations of both strains. As the treatment rate of latent individuals with drug sensitive TB,ϕs, increases, Re decreases so are the infectious populations with both strains. Thus, treating more latent individuals with drug sensitive TB can eliminate drug sensitive TB (Figures 10(a) and 10(c)). This is the case because as more latent individuals with drug sensitive TB are treated, then only a few of them will progress to active infection. Also, increasing ϕs reduces the number of infectious individuals with MDR-TB since the treatment will prevent the infection from developing resistance to the drugs. Although, this is the case, MDR-TB may not completely be eradicated from the population due to re-infection and relapse as illustrated in Figure 10(d), and also due to the fact that treatment efficacy is less than 100%. Figures 7(a) and 7(b) show that increasing ϕr reduces both Re and the latent and infectious populations with drug sensitive TB to zero over time. Treating more infectious individuals with drug sensitive TB prevents the infection from developing resistance to drugs and hence reduces the number of infectious population with MDR-TB as shown in Figure 7(d). However, Figure 7(d) also shows that, at this level of treatment, MDR-TB cannot be absolutely wiped out of the society which confirms the complexity of the disease. Figures 8(a) and 8(b) show that as the treatment rate of infectious individuals with MDR-TB, ϕ, increases, Rr reduces to less than unity and decreasing trends for latent and infectious individuals with MDR-TB are observed although they do not decay to zero due to the continuous development of resistance as treatment is not fully (or 100%) effective.Impact of varyingϕr on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)Impact of varyingϕ on the value of Rr and the dynamics of the number of (a) latent population with MDR-TB and (b) infectious population with MDR-TB.
(a)
(b)


#### 3.1.2. The Effect of Diagnosis on MDR-TB Dynamics

Figure9 shows that increasing the value of σ reduces Re and also decreases the infectious populations with drug sensitive and MDR-TB. From Figure 9(a), drug sensitive TB can be completely eliminated from the population if more people are diagnosed. This is mainly the case because usually diagnosis leads to treatment which reduces the infection (Figures 10, 7, and 8). On the contrary, diagnosis of more infectious individuals with drug sensitive TB is not a guarantee of eliminating MDR-TB as it only reduces the number of infectious individuals with MDR-TB but does not wipe the infection out of the population as illustrated by Figure 9(b). Therefore, increase in diagnosis should be correlated with increase in treatment to ensure treatment for all infectious individuals after they are detected.Impact of varyingσ on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB with respect to time.
(a)
(b)Impact of varyingϕs on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB, and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)


#### 3.1.3. The Effect of Health Education on MDR-TB Dynamics

Figure11 illustrates the importance of health education in the fight against MDR-TB. It is observed in Figure 11(a) that when more people receive health education on the importance of adhering to the doctor’s recommendation on how to take their TB regimens, the infectious population with drug sensitive TB decreases and eventually decays to zero. Also, this strategy reduces Re to further smaller values. Consequently, health education slightly reduces infectious individuals with MDR-TB as shown in Figure 11(b). This is possible because treatment adherence and compliance reduce the likelihood of the infection developing drug-resistance. However, Figure 11(b) also indicates that education alone is not enough to completely eliminate MDR-TB from the community as not all people will follow these rational instructions. In addition, exogenous re-infection and regression also make the efforts to root out MDR-TB difficult but not impossible. Thus, preventing re-infection and regression are viable. Figure 12 shows that as more infectious individuals with drug sensitive TB receive health education, the number of recovered population increases. This supports the fact that education has a positive impact on TB dynamics as depicted in Figure 11. Thus, educating more infectious individuals with drug sensitive TB increases the number of people recovering from the infection which is a positive development for the management of MDR-TB. Therefore, stepping up TB information/awareness campaigns should be given prominence in TB control programmes.Impact of varyinga on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB.
(a)
(b)Figure 12
Impact of health education on the dynamics of recovered population.


## 3.1. Dynamics of the Populations under Different Interventions

### 3.1.1. The Effect of Treatment on MDR-TB Dynamics

It is assumed under this scenario that treatment is given to latent and infectious individuals with drug sensitive TB as well as infectious individuals with MDR-TB. We then investigate the impact of each of these control measures on all the infected populations of both strains. As the treatment rate of latent individuals with drug sensitive TB,ϕs, increases, Re decreases so are the infectious populations with both strains. Thus, treating more latent individuals with drug sensitive TB can eliminate drug sensitive TB (Figures 10(a) and 10(c)). This is the case because as more latent individuals with drug sensitive TB are treated, then only a few of them will progress to active infection. Also, increasing ϕs reduces the number of infectious individuals with MDR-TB since the treatment will prevent the infection from developing resistance to the drugs. Although, this is the case, MDR-TB may not completely be eradicated from the population due to re-infection and relapse as illustrated in Figure 10(d), and also due to the fact that treatment efficacy is less than 100%. Figures 7(a) and 7(b) show that increasing ϕr reduces both Re and the latent and infectious populations with drug sensitive TB to zero over time. Treating more infectious individuals with drug sensitive TB prevents the infection from developing resistance to drugs and hence reduces the number of infectious population with MDR-TB as shown in Figure 7(d). However, Figure 7(d) also shows that, at this level of treatment, MDR-TB cannot be absolutely wiped out of the society which confirms the complexity of the disease. Figures 8(a) and 8(b) show that as the treatment rate of infectious individuals with MDR-TB, ϕ, increases, Rr reduces to less than unity and decreasing trends for latent and infectious individuals with MDR-TB are observed although they do not decay to zero due to the continuous development of resistance as treatment is not fully (or 100%) effective.Impact of varyingϕr on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)Impact of varyingϕ on the value of Rr and the dynamics of the number of (a) latent population with MDR-TB and (b) infectious population with MDR-TB.
(a)
(b)


### 3.1.2. The Effect of Diagnosis on MDR-TB Dynamics

Figure9 shows that increasing the value of σ reduces Re and also decreases the infectious populations with drug sensitive and MDR-TB. From Figure 9(a), drug sensitive TB can be completely eliminated from the population if more people are diagnosed. This is mainly the case because usually diagnosis leads to treatment which reduces the infection (Figures 10, 7, and 8). On the contrary, diagnosis of more infectious individuals with drug sensitive TB is not a guarantee of eliminating MDR-TB as it only reduces the number of infectious individuals with MDR-TB but does not wipe the infection out of the population as illustrated by Figure 9(b). Therefore, increase in diagnosis should be correlated with increase in treatment to ensure treatment for all infectious individuals after they are detected.Impact of varyingσ on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB with respect to time.
(a)
(b)Impact of varyingϕs on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB, and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)


### 3.1.3. The Effect of Health Education on MDR-TB Dynamics

Figure11 illustrates the importance of health education in the fight against MDR-TB. It is observed in Figure 11(a) that when more people receive health education on the importance of adhering to the doctor’s recommendation on how to take their TB regimens, the infectious population with drug sensitive TB decreases and eventually decays to zero. Also, this strategy reduces Re to further smaller values. Consequently, health education slightly reduces infectious individuals with MDR-TB as shown in Figure 11(b). This is possible because treatment adherence and compliance reduce the likelihood of the infection developing drug-resistance. However, Figure 11(b) also indicates that education alone is not enough to completely eliminate MDR-TB from the community as not all people will follow these rational instructions. In addition, exogenous re-infection and regression also make the efforts to root out MDR-TB difficult but not impossible. Thus, preventing re-infection and regression are viable. Figure 12 shows that as more infectious individuals with drug sensitive TB receive health education, the number of recovered population increases. This supports the fact that education has a positive impact on TB dynamics as depicted in Figure 11. Thus, educating more infectious individuals with drug sensitive TB increases the number of people recovering from the infection which is a positive development for the management of MDR-TB. Therefore, stepping up TB information/awareness campaigns should be given prominence in TB control programmes.Impact of varyinga on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB.
(a)
(b)Figure 12
Impact of health education on the dynamics of recovered population.


## 3.1.1. The Effect of Treatment on MDR-TB Dynamics

It is assumed under this scenario that treatment is given to latent and infectious individuals with drug sensitive TB as well as infectious individuals with MDR-TB. We then investigate the impact of each of these control measures on all the infected populations of both strains. As the treatment rate of latent individuals with drug sensitive TB,ϕs, increases, Re decreases so are the infectious populations with both strains. Thus, treating more latent individuals with drug sensitive TB can eliminate drug sensitive TB (Figures 10(a) and 10(c)). This is the case because as more latent individuals with drug sensitive TB are treated, then only a few of them will progress to active infection. Also, increasing ϕs reduces the number of infectious individuals with MDR-TB since the treatment will prevent the infection from developing resistance to the drugs. Although, this is the case, MDR-TB may not completely be eradicated from the population due to re-infection and relapse as illustrated in Figure 10(d), and also due to the fact that treatment efficacy is less than 100%. Figures 7(a) and 7(b) show that increasing ϕr reduces both Re and the latent and infectious populations with drug sensitive TB to zero over time. Treating more infectious individuals with drug sensitive TB prevents the infection from developing resistance to drugs and hence reduces the number of infectious population with MDR-TB as shown in Figure 7(d). However, Figure 7(d) also shows that, at this level of treatment, MDR-TB cannot be absolutely wiped out of the society which confirms the complexity of the disease. Figures 8(a) and 8(b) show that as the treatment rate of infectious individuals with MDR-TB, ϕ, increases, Rr reduces to less than unity and decreasing trends for latent and infectious individuals with MDR-TB are observed although they do not decay to zero due to the continuous development of resistance as treatment is not fully (or 100%) effective.Impact of varyingϕr on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)Impact of varyingϕ on the value of Rr and the dynamics of the number of (a) latent population with MDR-TB and (b) infectious population with MDR-TB.
(a)
(b)


## 3.1.2. The Effect of Diagnosis on MDR-TB Dynamics

Figure9 shows that increasing the value of σ reduces Re and also decreases the infectious populations with drug sensitive and MDR-TB. From Figure 9(a), drug sensitive TB can be completely eliminated from the population if more people are diagnosed. This is mainly the case because usually diagnosis leads to treatment which reduces the infection (Figures 10, 7, and 8). On the contrary, diagnosis of more infectious individuals with drug sensitive TB is not a guarantee of eliminating MDR-TB as it only reduces the number of infectious individuals with MDR-TB but does not wipe the infection out of the population as illustrated by Figure 9(b). Therefore, increase in diagnosis should be correlated with increase in treatment to ensure treatment for all infectious individuals after they are detected.Impact of varyingσ on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB with respect to time.
(a)
(b)Impact of varyingϕs on Re and on the number of (a) latent population with drug sensitive TB, (b) infectious population with drug sensitive TB, (c) latent population with MDR-TB, and (d) infectious population with MDR-TB.
(a)
(b)
(c)
(d)


## 3.1.3. The Effect of Health Education on MDR-TB Dynamics

Figure11 illustrates the importance of health education in the fight against MDR-TB. It is observed in Figure 11(a) that when more people receive health education on the importance of adhering to the doctor’s recommendation on how to take their TB regimens, the infectious population with drug sensitive TB decreases and eventually decays to zero. Also, this strategy reduces Re to further smaller values. Consequently, health education slightly reduces infectious individuals with MDR-TB as shown in Figure 11(b). This is possible because treatment adherence and compliance reduce the likelihood of the infection developing drug-resistance. However, Figure 11(b) also indicates that education alone is not enough to completely eliminate MDR-TB from the community as not all people will follow these rational instructions. In addition, exogenous re-infection and regression also make the efforts to root out MDR-TB difficult but not impossible. Thus, preventing re-infection and regression are viable. Figure 12 shows that as more infectious individuals with drug sensitive TB receive health education, the number of recovered population increases. This supports the fact that education has a positive impact on TB dynamics as depicted in Figure 11. Thus, educating more infectious individuals with drug sensitive TB increases the number of people recovering from the infection which is a positive development for the management of MDR-TB. Therefore, stepping up TB information/awareness campaigns should be given prominence in TB control programmes.Impact of varyinga on the value of Re and the dynamics of the number of (a) infectious population with drug sensitive TB and (b) infectious population with MDR-TB.
(a)
(b)Figure 12
Impact of health education on the dynamics of recovered population.


## 4. Discussion and Conclusion

A two-strain TB model with diagnosis, treatment, and health education is formulated and analyzed. The main objective of this theoretical study was to assess the impact of these control strategies on the transmission dynamics of MDR-TB (with Malawi as a case study). We note however that the results presented are general and can be applied to other settings because neither the model, nor the parameters values represent characteristics unique of Malawi. The effective reproduction number was computed and used to compare the effect of each intervention strategy on the MDR-TB dynamics.Using the theory of dynamical systems, qualitative analysis shows that the model has two equilibria the disease-free equilibrium and endemic equilibrium. Using the next-generation operator approach, it was found that, whenever the threshold that describes endemic persistence of the disease,Re<1 (i.e., Rs<1 and Rr<1), the disease-free equilibrium is locally asymptotically stable and becomes unstable whenever Re>1 (Rs>1 and Rr>1). The existence and stability of the endemic equilibrium was determined using the Center Manifold theory [22]. Near the threshold Re=1, there exists a stable endemic equilibrium which is locally asymptotically stable for Re>1. In the absence of interventions, the effective reproduction number, Re, reduces to the basic reproduction number R0. As customary in epidemiological models, the disease-free and endemic equilibria are found and their stability is investigated depending on the system parameters. Because of the occurrence of backward bifurcation in some parameter regimes, the system exhibits a bistability between a disease-free and endemic steady states. Whether the parameter values for which this phenomenon arises are biologically realistic remains a conjecture as field data will be needed to parameterize such occurrence. The Centre Manifold theory was used to determine the local asymptotic stability of the endemic equilibrium. Our results provide a perspective for understanding the complexity of MDR-TB, and the model can be applied in most settings where MDR-TB is present.Numerical simulations suggest that, in the absence of any intervention, both TB strains cannot be eliminated from the population asR0>1, and the disease persists at an endemic equilibrium. A critical factor in addressing MDR-TB is primary prevention through DOTS and management of patients requiring second-line drug-regimen. Treatment of latent and infectious individuals with sensitive TB showed that ordinary TB can be completely eradicated. Thus, effective treatment for latent and infectious individuals with ordinary TB results in a reduction of MDR-TB, since the emergence of most MDR-TB cases is due to failure to provide TB drugs on time, as identifying latently infected individuals with sensitive and putting them on treatment is crucial in reducing new cases of resistant TB [29]. Also effective chemoprophylaxis and treatment of infectives result in a reduction of MDR-TB cases since most MDR-TB cases are a result of inappropriate treatment [5]. Treatment for infectious individuals with MDR-TB alters TB epidemics because it reduces the spread of MDR-TB strains and this supports the analytical results. Hence, a decrease in MDR-TB cases implies a decrease in MDR-TB-related deaths as MDR-TB kills more people than ordinary TB.Diagnosis also plays an important role in MDR-TB reduction. As the proportion of TB patients being presented for diagnosis is increased, the rate of treatment should be correlated to the number of diagnosed infected individuals so as to reduce the burden of TB [6]. Significant increase in the detection rate of infectious individuals in Nigeria has been recommended because DOTS failed to reduce the incidence rate in the country due to failure to adequately detect a huge number of active TB cases which are primarily responsible for the spread of the infection [30]. As more people go for TB diagnosis, MDR-TB decreases due to the fact that those diagnosed with the disease are placed on DOTS. Drug-resistant TB will remain a serious threat to our communities as long as many members of our society do not have regular access to medical care [31]. Health education is another important aspect in the fight against MDR-TB. Results showed that, if more people receive health education, then the burden of MDR-TB can be reduced since MDR-TB cases also arise due to noncompliance with TB treatment. Information/awareness campaigns are viable in order to sensitize people on the importance of completing their TB dosages. Despite the role of the control strategies in reducing the burden of MDR-TB, numerical simulations also show that at the current level of TB treatment, diagnosis and health education, MDR-TB can only be reduced significanly.Incomplete data from the National TB Control Program proves to be a major challenge in deriving estimates for the key biological parameters to calibrate the model to Malawi. Nevertheless, resorting to the literature, fundamental parameters values mimicking the epidemic in the region were used as a basis for illustration. Although several assumptions are made in the process, our results are driven by the model formulation and its structure; however, they are applicable to the Malawi context and other settings with similar epidemic trend. In summary, adequate treatment of sensitive TB will result in a reduction of MDR-TB in Malawi as most MDR-TB cases come from failure to properly administer TB drugs. Furthermore, diagnosis and health education of infectives with sensitive TB is important in the reduction of new MDR-TB cases due to adherence and compliance to treatment. Scaling up diagnosis, treating, and TB education will help in reducing the burden of the disease. Treatment rate of infected individuals should be correlated to the number of diagnosed individuals, and policies should be put in place to minimize loss to follow up. MDR-TB eradication remains a challenge to National Tuberculosis Control Programs in most developing countries, hence strengthening control strategies is paramount to curtailing TB spread, especially as the incidence rate of MDR-TB seems to be on the increase.Finally, we identify some limitations of this study. A more realistic perspective could have been achieved by including, vaccination of susceptible population, immigrants, and new born; efficacy of MDR-TB drugs and information campaigns; controlling the disease with a possible minimal cost and side effects using control theory; estimating the cost-effectiveness of these control measures. Most parameter values are obtained from different sources giving rise to parameter uncertainty regarding their exact value. Our results which are driven by the model structure and its formulation are sensitive to the choice of parameter values. However, it is worth stressing that the main goal of this work was to provide a theoretical framework where the emergence of drug-resistant and MDR-TB can be addressed using a dynamical model. We focused on the population-level dynamics and potential benefits associated with implementation of various control strategies. It is our hope that the theoretical results obtained from this study will stimulate further interest in developing more complex models, be it agent based or network.



---

*Source: 459829-2012-08-16.xml*